Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer's disease.
Acetylcholinesterase
/ metabolism
Alzheimer Disease
/ drug therapy
Amaryllidaceae Alkaloids
/ chemistry
Butyrylcholinesterase
/ metabolism
Cholinesterase Inhibitors
/ chemistry
Dose-Response Relationship, Drug
Glycogen Synthase Kinase 3 beta
/ antagonists & inhibitors
Humans
Molecular Structure
Narcissus
/ chemistry
Neuroprotective Agents
/ chemistry
Prolyl Oligopeptidases
Serine Endopeptidases
/ metabolism
Structure-Activity Relationship
Alkaloids
Alzheimer's disease
Amaryllidaceae
Cholinesterase inhibition
Glycogen synthase kinase-3β inhibition
Narcimatuline
Narcissus pseudonarcissus L. cv. Dutch master
Prolyl oligopeptidase
Journal
Phytochemistry
ISSN: 1873-3700
Titre abrégé: Phytochemistry
Pays: England
ID NLM: 0151434
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
07
03
2019
revised:
27
05
2019
accepted:
23
06
2019
pubmed:
2
7
2019
medline:
16
8
2019
entrez:
2
7
2019
Statut:
ppublish
Résumé
Twenty-one known Amaryllidaceae alkaloids of various structural types and one undescribed alkaloid, named narcimatuline, have been isolated from fresh bulbs of Narcissus pseudonarcissus L. cv. Dutch Master. The chemical structures were elucidated by combination of MS, HRMS, 1D and 2D NMR spectroscopic techniques, and by comparison with literature data. Narcimatuline amalgamates two basic scaffolds of Amaryllidaceae alkaloids in its core, namely galanthamine and galanthindole. All isolated compounds were evaluated for their in vitro acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), prolyl oligopeptidase (POP), and glycogen synthase kinase-3β (GSK-3β) inhibitory activities. The most interesting biological profile was demonstrated by newly isolated alkaloid narcimatuline.
Identifiants
pubmed: 31261031
pii: S0031-9422(19)30197-9
doi: 10.1016/j.phytochem.2019.112055
pii:
doi:
Substances chimiques
Amaryllidaceae Alkaloids
0
Cholinesterase Inhibitors
0
Neuroprotective Agents
0
Glycogen Synthase Kinase 3 beta
EC 2.7.11.1
Acetylcholinesterase
EC 3.1.1.7
Butyrylcholinesterase
EC 3.1.1.8
Serine Endopeptidases
EC 3.4.21.-
PREPL protein, human
EC 3.4.21.26
Prolyl Oligopeptidases
EC 3.4.21.26
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112055Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.